Target intelligence / Profile preview

Gonadotropin-releasing hormone receptor (GnRHR)

Target
GnRHR
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

The **gonadotropin-releasing hormone receptor** (**GnRHR**) is a seven-transmembrane G protein-coupled receptor primarily expressed on pituitary gonadotrope cells. It mediates the action of hypothalamic gonadotropin-releasing hormone (GnRH), which stimulates synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are essential for gametogenesis and steroidogenesis in both sexes. The activation pathway involves coupling with Gq/11 proteins leading to phospholipase C activation and downstream signaling cascades. Clinically, this target is modulated by both agonist and antagonist drugs for indications such as infertility treatment as well as sex steroid-dependent cancers. The original query referred to "luteinizing hormone release modulation," which describes a physiological process rather than a specific molecular entity; thus it should be mapped specifically to its canonical mediator—the **gonadotropin-releasing hormone receptor**[2][3][4].

Other names
Luteinizing hormone-releasing hormone receptorLHRHRGnRH receptorGNRHR
02

Mechanism of action

Agonists stimulate the GnRHR to increase LH/FSH secretion initially; chronic stimulation leads to desensitization/downregulation and suppression of gonadotropins. Antagonists block the GnRHR to immediately suppress LH/FSH secretion.

03

Biological functions

Signal transductionRegulation of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretionCentral control of reproduction
04

Disease associations

Cancer (notably breast, ovary, and prostate cancers)Infertility/reproductive disordersOther endocrine disorders
05

Safety considerations

Hypogonadism with long-term use of agonists or antagonistsBone mineral density loss due to sex steroid suppressionMenopausal symptoms in women; testosterone deficiency symptoms in men
06

Interacting drugs

GnRH agonists (e.g., leuprolide, goserelin)

2 more in the full profile.

07

Biomarkers

Circulating luteinizing hormone levels for efficacy monitoring in reproductive medicine

Beyond the preview

Go deeper on Gonadotropin-releasing hormone receptor (GnRHR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gonadotropin-releasing hormone receptor (GnRHR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call